Regulatory effects of the combination of berberine and ginsenoside Rb1 on high-fat diet-induced nonalcoholic fatty liver disease via AMPK pathway and improved pharmacokinetics

著录项

• 来源
  《TMR整合医学》 |2018年第2期|P.76-86|共11页
• 作者

  Lv Zhou; Xiu-Teng Zhou; Wen-Bo Xu; Yi-Dan Chen; Ni-Hua Wang; Jiao Guo; Hui Fan;

  展开▼
• 作者单位

  [1]Guangdong Research Center of Metabolic Diseases of Integrated Western and Chinese Medicine Guangdong Pharmaceutical University Guangzhou 510006 China;

  [2]Joint Laboratory between Guangdong and Hong Kong on Metabolic Disease Guangdong Pharmaceutical University Guangzhou 510006 China;

  [3]National Resource Center for Chinese Materia Medica China Academy of Chinese Medical Sciences State Key Laboratory Breeding Base of Daodi Herbs Beijng 100700 China;

  展开▼
• 原文格式 PDF
• 正文语种 chi
• 中图分类 医药、卫生;
• 关键词

  非酒精性脂肪肝; AMP活化蛋白激酶; 小檗碱; 人参皂苷Rb1; 药代动力学; 肠道细菌;